These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19289477)

  • 41. Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.
    Okubadejo NU; Ojo OO; Oshinaike OO
    BMC Neurol; 2010 Jan; 10():1. PubMed ID: 20051133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tremor-related quality of life: A comparison of essential tremor vs. Parkinson's disease patients.
    Louis ED; Machado DG
    Parkinsonism Relat Disord; 2015 Jul; 21(7):729-35. PubMed ID: 25952960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elderly-onset essential tremor is associated with dementia.
    Benito-León J; Louis ED; Bermejo-Pareja F;
    Neurology; 2006 May; 66(10):1500-5. PubMed ID: 16717208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism.
    Li Y; McLernon DJ; Counsell CE; Macleod AD
    Parkinsonism Relat Disord; 2024 Jan; 118():105928. PubMed ID: 37980851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence of increased odds of essential tremor in Parkinson's disease.
    Tan EK; Lee SS; S FC; Lum SY
    Mov Disord; 2008 May; 23(7):993-997. PubMed ID: 18383536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of motor and non-motor features between essential tremor and tremor dominant Parkinson's disease.
    Kwon KY; Lee HM; Lee SM; Kang SH; Koh SB
    J Neurol Sci; 2016 Feb; 361():34-8. PubMed ID: 26810513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
    Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
    Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Faster rate of cognitive decline in essential tremor cases than controls: a prospective study.
    Louis ED; Benito-León J; Vega-Quiroga S; Bermejo-Pareja F;
    Eur J Neurol; 2010 Oct; 17(10):1291-7. PubMed ID: 20561042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elderly-onset essential tremor and mild cognitive impairment: a population-based study (NEDICES).
    Benito-León J; Louis ED; Mitchell AJ; Bermejo-Pareja F
    J Alzheimers Dis; 2011; 23(4):727-35. PubMed ID: 21304183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control.
    Lee SM; Kim M; Lee HM; Kwon KY; Koh SB
    J Neurol Sci; 2015 Feb; 349(1-2):168-73. PubMed ID: 25641389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
    Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical, neuropsychological and epidemiological aspects of the 'transitional' form of Parkinson's disease in the Yaroslavl region].
    Pizova NV; Bykanova MA; Kurapin EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):66-71. PubMed ID: 31156225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor.
    Miller KM; Okun MS; Fernandez HF; Jacobson CE; Rodriguez RL; Bowers D
    Mov Disord; 2007 Apr; 22(5):666-72. PubMed ID: 17266084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study.
    de Lau LM; Giesbergen PC; de Rijk MC; Hofman A; Koudstaal PJ; Breteler MM
    Neurology; 2004 Oct; 63(7):1240-4. PubMed ID: 15477545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
    Viñes JJ; Larumbe R; Gaminde I; Artázcoz MT
    Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition?
    Ondo WG; Lai D
    Mov Disord; 2005 Apr; 20(4):471-475. PubMed ID: 15597336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Neurofilament Light With the Development and Severity of Parkinson Disease.
    Halloway S; Desai P; Beck T; Aggarwal N; Agarwal P; Evans D; Rajan KB;
    Neurology; 2022 May; 98(22):e2185-e2193. PubMed ID: 35418452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burden of Parkinsonism and Parkinson's Disease on Health Service Use and Outcomes in Latin America.
    Kim DJ; Rodriguez-Salgado AM; Llibre-Rodriguez JJ; Acosta I; Sosa AL; Acosta D; Jimenez-Velasquez IZ; Guerra M; Salas A; Jeyachandran C; López-Contreras R; Hesse H; Tanner C; Llibre-Guerra JJ; Prina M
    J Parkinsons Dis; 2023; 13(7):1199-1211. PubMed ID: 37742660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom.
    Hobson P; Gallacher J; Meara J
    Mov Disord; 2005 Aug; 20(8):995-8. PubMed ID: 15852368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.